Evidence map›Paper›PMID 38659833›Full record

ArticlebioRxiv : the preprint server for biology2024

PAbFold: Linear Antibody Epitope Prediction using AlphaFold2.

Jacob DeRoo, James S Terry, Ning Zhao, Timothy J Stasevich, Christopher D Snow, Brian J Geiss

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jacob DeRooSchool of Biomedical Engineering, Colorado State University, Fort Collins CO USA.
James S TerryDepartment of Microbiology, Immunology, & Pathology, Colorado State University, Fort Collins CO USA.
Ning ZhaoDepartment of Biochemistry and Molecular Genetics, University of Colorado-Anschutz Medical Campus, Aurora, CO USA.
Timothy J StasevichDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins CO USA.ORCID 0000-0002-0151-6274
Christopher D SnowSchool of Biomedical Engineering, Colorado State University, Fort Collins CO USA.
Brian J GeissSchool of Biomedical Engineering, Colorado State University, Fort Collins CO USA.ORCID 0000-0001-8180-5772
Colorado State University · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Multiplexed imaging of viral protein processing and assembly in live cellsR01AI168459 · NIAID · COLORADO STATE UNIVERSITY · PI Christopher Davis Snow · 2022 to 2026
$2.3M
CSU Infectious Disease Research and Response Training ProgramT32AI162691 · NIAID · COLORADO STATE UNIVERSITY · PI DEAN, GREGG A · 2021 to 2025
$2.1M
Mechanism of Flavivirus RNA CappingR01AI132668 · NIAID · COLORADO STATE UNIVERSITY · PI GEISS, BRIAN · 2018 to 2022
$1.9M
Multiplexed imaging of viral protein processing and assembly in live cellsR56AI155897 · NIAID · COLORADO STATE UNIVERSITY · PI SNOW, CHRISTOPHER DAVIS, STASEVICH, TIMOTHY · 2021 to 2021
$518k
NIAID NIH HHS R01 AI132668NIAID NIH HHS R01 AI168459NIAID NIH HHS R56 AI155897NIAID NIH HHS T32 AI162691
6 · The paper itself

Abstract

Defining the binding epitopes of antibodies is essential for understanding how they bind to their antigens and perform their molecular functions. However, while determining linear epitopes of monoclonal antibodies can be accomplished utilizing well-established empirical procedures, these approaches are generally labor- and time-intensive and costly. To take advantage of the recent advances in protein structure prediction algorithms available to the scientific community, we developed a calculation pipeline based on the localColabFold implementation of AlphaFold2 that can predict linear antibody epitopes by predicting the structure of the complex between antibody heavy and light chains and target peptide sequences derived from antigens. We found that this AlphaFold2 pipeline, which we call PAbFold, was able to accurately flag known epitope sequences for several well-known antibody targets (HA / Myc) when the target sequence was broken into small overlapping linear peptides and antibody complementarity determining regions (CDRs) were grafted onto several different antibody framework regions in the single-chain antibody fragment (scFv) format. To determine if this pipeline was able to identify the epitope of a novel antibody with no structural information publicly available, we determined the epitope of a novel anti-SARS-CoV-2 nucleocapsid targeted antibody using our method and then experimentally validated our computational results using peptide competition ELISA assays. These results indicate that the AlphaFold2-based PAbFold pipeline we developed is capable of accurately identifying linear antibody epitopes in a short time using just antibody and target protein sequences. This emergent capability of the method is sensitive to methodological details such as peptide length, AlphaFold2 neural network versions, and multiple-sequence alignment database. PAbFold is available at https://github.com/jbderoo/PAbFold.

Indexed as

AlphaFold2antibodycompetition ELISAepitope-predictionlinear epitopescFv

Identifiers

PMID38659833
PMCPMC11042291
OpenAlexW4394978153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.